148 related articles for article (PubMed ID: 26771067)
1. Progressive vascular remodelling, endothelial dysfunction and stiffness in mesenteric resistance arteries in a rodent model of chronic kidney disease.
Quek KJ; Boyd R; Ameer OZ; Zangerl B; Butlin M; Murphy TV; Avolio AP; Phillips JK
Vascul Pharmacol; 2016 Jun; 81():42-52. PubMed ID: 26771067
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease.
Ameer OZ; Butlin M; Kaschina E; Sommerfeld M; Avolio AP; Phillips JK
J Vasc Res; 2016; 53(3-4):216-229. PubMed ID: 27880955
[TBL] [Abstract][Full Text] [Related]
3. AT1 Receptor Antagonism Improves Structural, Functional, and Biomechanical Properties in Resistance Arteries in a Rodent Chronic Kidney Disease Model.
Quek KJ; Ameer OZ; Phillips JK
Am J Hypertens; 2018 May; 31(6):696-705. PubMed ID: 29425281
[TBL] [Abstract][Full Text] [Related]
4. Amlodipine Improves Vessel Function and Remodeling in the Lewis Polycystic Kidney Rat Mesenteric Artery.
Quek KJ; Ameer OZ; Phillips JK
Am J Hypertens; 2020 Jul; 33(7):634-643. PubMed ID: 32215654
[TBL] [Abstract][Full Text] [Related]
5. Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries.
Kahlberg N; Qin CX; Anthonisz J; Jap E; Ng HH; Jelinic M; Parry LJ; Kemp-Harper BK; Ritchie RH; Leo CH
Pharmacol Res; 2016 Sep; 111():325-335. PubMed ID: 27363948
[TBL] [Abstract][Full Text] [Related]
6. Altered reactivity of resistance vasculature contributes to hypertension in elastin insufficiency.
Osei-Owusu P; Knutsen RH; Kozel BA; Dietrich HH; Blumer KJ; Mecham RP
Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H654-66. PubMed ID: 24414067
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
Parente JM; Pereira CA; Oliveira-Paula GH; Tanus-Santos JE; Tostes RC; Castro MM
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
[TBL] [Abstract][Full Text] [Related]
8. Vasopeptidase Inhibition Corrects the Structure and Function of the Small Arteries in Experimental Renal Insufficiency.
Haltia O; Törmänen S; Eräranta A; Jokihaara J; Nordhausen K; Rysä J; Ruskoaho H; Tikkanen I; Mustonen J; Pörsti I
J Vasc Res; 2015; 52(2):94-102. PubMed ID: 26184548
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension.
Bagnost T; Ma L; da Silva RF; Rezakhaniha R; Houdayer C; Stergiopulos N; André C; Guillaume Y; Berthelot A; Demougeot C
Cardiovasc Res; 2010 Aug; 87(3):569-77. PubMed ID: 20219858
[TBL] [Abstract][Full Text] [Related]
10. Chronic iron overload induces functional and structural vascular changes in small resistance arteries via NADPH oxidase-dependent O
Ribeiro Júnior RF; Marques VB; Nunes DO; Stefanon I; Dos Santos L
Toxicol Lett; 2017 Sep; 279():43-52. PubMed ID: 28700905
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D
Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 preserves flow-mediated remodelling in old obese Zucker rat mesenteric arteries.
Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Loufrani L; Henrion D
Cardiovasc Res; 2010 Jun; 86(3):516-25. PubMed ID: 20032084
[TBL] [Abstract][Full Text] [Related]
13. Vascular effects of aerobic exercise training in rat adult offspring exposed to hypoxia-induced intrauterine growth restriction.
Reyes LM; Morton JS; Kirschenman R; DeLorey DS; Davidge ST
J Physiol; 2015 Apr; 593(8):1913-29. PubMed ID: 25616117
[TBL] [Abstract][Full Text] [Related]
14. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat.
Ochodnický P; Henning RH; Buikema HJ; de Zeeuw D; Provoost AP; van Dokkum RP
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F625-33. PubMed ID: 20007352
[TBL] [Abstract][Full Text] [Related]
15. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction in rat mesenteric artery after regional cardiac ischaemia-reperfusion.
Zhao M; He X; Wier WG; Zhang HL; Zhao M; Yu XJ; Zang WJ
Exp Physiol; 2012 Jan; 97(1):70-9. PubMed ID: 21948192
[TBL] [Abstract][Full Text] [Related]
17. Tributyltin chloride increases phenylephrine-induced contraction and vascular stiffness in mesenteric resistance arteries from female rats.
Ribeiro Júnior RF; Marques VB; Nunes DO; Ronconi Kde S; de Araújo JF; Rodrigues PL; Padilha AS; Vassallo DV; Graceli JB; Stefanon I
Toxicol Appl Pharmacol; 2016 Mar; 295():26-36. PubMed ID: 26873547
[TBL] [Abstract][Full Text] [Related]
18. Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model.
Ng K; Hildreth CM; Phillips JK; Avolio AP
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1431-6. PubMed ID: 21478483
[TBL] [Abstract][Full Text] [Related]
19. Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase.
Al-Hashmi S; Boels PJ; Zadjali F; Sadeghi B; Sällström J; Hultenby K; Hassan Z; Arner A; Hassan M
PLoS One; 2012; 7(1):e30897. PubMed ID: 22303468
[TBL] [Abstract][Full Text] [Related]
20. Estrogens are needed for the improvement in endothelium-mediated dilation induced by a chronic increase in blood flow in rat mesenteric arteries.
Tarhouni K; Guihot AL; Vessieres E; Procaccio V; Grimaud L; Abraham P; Lenfant F; Arnal JF; Favre J; Loufrani L; Henrion D
Vascul Pharmacol; 2016 May; 80():35-42. PubMed ID: 26471832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
